Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

775
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
775
Cranial and Spinal Meninges01:19

Cranial and Spinal Meninges

3.5K
The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
3.5K
Pneumonia IV: Management01:28

Pneumonia IV: Management

749
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
749
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

305
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
305
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

314
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
314
Stages of Infection01:26

Stages of Infection

64.8K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
64.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antimicrobial resistance burden landscape in Germany in 2019: a comparative country-level estimation.

JAC-antimicrobial resistance·2025
Same author

SARS-CoV-2 Screening Testing in Schools: A Comparison of School- Vs. Home-Based Collection Methods.

Journal of the Pediatric Infectious Diseases Society·2022
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.6K

Clinical progress note: Invasive meningococcal disease.

Alaina Shine1, Erin Chung2,3,4

  • 1Department of Pediatrics, Division of Hospital Medicine, University of Washington, Seattle, Washington, USA.

Journal of Hospital Medicine
|October 27, 2025
PubMed
Summary

Invasive meningococcal disease cases are rising in the US. Clinicians need updated knowledge on recognizing, managing, and preventing this serious Neisseria meningitidis infection, emphasizing current vaccine strategies.

More Related Videos

Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model
07:26

Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model

Published on: July 1, 2018

7.7K
Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

8.9K

Related Experiment Videos

Last Updated: Jan 14, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.6K
Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model
07:26

Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model

Published on: July 1, 2018

7.7K
Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

8.9K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Invasive meningococcal disease (IMD) caused by Neisseria meningitidis has seen a decline in the US since the late 1990s.
  • This decline has resulted in reduced clinical experience with IMD diagnosis and management.
  • Recent increases in IMD cases since 2021 necessitate renewed clinician focus.

Purpose of the Study:

  • To provide clinicians with updated information on invasive meningococcal disease.
  • To review current literature and guidance for prevention, recognition, and management.
  • To address the urgency created by the recent rise in IMD cases.

Main Methods:

  • This is a review article.
  • It summarizes recent literature and clinical guidance.
  • Focuses on prevention, early recognition, and management strategies.

Main Results:

  • Invasive meningococcal disease (Neisseria meningitidis) has seen an increase in the US since 2021.
  • Clinicians require updated knowledge on signs, sequelae, and management.
  • Current vaccine recommendations are crucial for prevention.

Conclusions:

  • Clinicians must re-familiarize themselves with invasive meningococcal disease due to rising cases.
  • Staying updated on Neisseria meningitidis prevention, recognition, and management is critical.
  • Adherence to current vaccine recommendations is essential for controlling this vaccine-preventable disease.